EMPLOYMENT AGREEEMENTEmployment Agreement • August 5th, 2022 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledAugust 5th, 2022 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made between Candel Therapeutics, Inc., a Delaware corporation (the “Company”), and Seshu Tyagarajan (the “Executive”) and is made effective as of April 14, 2022 or a mutually agreeable start date.
EMPLOYMENT AGREEEMENTEmployment Agreement • May 12th, 2022 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledMay 12th, 2022 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made between Candel Therapeutics, Inc., a Delaware corporation (the “Company”), and Seshu Tyagarajan (the “Executive”) and is made effective as of April 14, 2022 or a mutually agreeable start date.
EMPLOYMENT AGREEEMENTEmployment Agreement • July 16th, 2021 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made between Advantagene Inc., a Delaware corporation d/b/a Candel Therapeutics (the “Company”), and Nathan Caffo (the “Executive”) and is made effective as of 24 Sept. 2020 (the Effective Date”).
EMPLOYMENT AGREEMENTEmployment Agreement • July 16th, 2021 • Candel Therapeutics, Inc. • Biological products, (no disgnostic substances) • Massachusetts
Contract Type FiledJuly 16th, 2021 Company Industry JurisdictionThis Employment Agreement (“Agreement”) is made between Advantagene Inc., a Delaware corporation d/b/a Candel Therapeutics (the “Company”), and John Canepa (the “Executive”) and is made effective as of December 1, 2020 (the “Effective Date”).